About us

Full Lifecycle Investment Platform

Why We Exist

The firm is focused on understanding how physical, biological, and engineered systems are formed, constrained, and operated, and how those conditions determine the direction and performance of assets, projects, and businesses. Assets are treated as direct expressions of underlying systems, where performance emerges from how those systems are configured and where their limits sit, rather than from surface level positioning.

SKGP operates on the premise that scientific and technical constraints define what is possible, and that identifying where those constraints are shifting or can be overcome determines whether an asset can be advanced, reconfigured, or repositioned in a way that materially changes its trajectory. Capital structure, ownership, and governance are then designed to enable and capture that transition.

This system level understanding defines the direction of the opportunity and is translated into financial structure and execution through the use of specialized partners across capital structuring, restructuring, and operations, allowing the firm to act across situations including growth investments, buyouts, structured transactions, carve outs, and distressed opportunities, wherever insight into the underlying system and the right structure of capital and ownership together create a clear path to change the direction of the asset or business.

Specialist partners are selected and embedded across strategies, processes, and approaches, with their track records and areas of expertise explicitly mapped to each investment vehicle, fund strategy, or opportunity.

Investment Thesis

Scientific And Technical Research

Intial process is the direct study of the system itself. This includes the physical, biological, or engineered mechanisms that govern how the asset or business operates. In physical systems, this involves energy ,materials, extraction methods, processing, logistics, infrastructure, and geographic constraints. In biological systems, this involves disease pathways, molecular mechanisms, diagnostics, lifesciences, clinical workflows, regulatory structure, and reimbursement dynamics. In engineered systems, this involves computation, data systems, automation, artificial intelligence, quantum computing and infrastructure integration.

The objective is to determine what is technically possible within the system and whether that boundary is changing. This includes identifying new methods, new science, new processes, new materials, new biological pathways, new computational capabilities, new infrastructure configurations, or new operating approaches that alter what the system can produce or how efficiently it can operate.
Our Differentiated view focus on whether the underlying mechanism itself is shifting. A system may appear constrained at the surface level while remaining underdeveloped at the scientific or technical level. Conversely, a system may be fully constrained by physics, biology, or engineering, in which case capital alone cannot change its outcome. The distinction between these conditions determines whether an opportunity exists.

Comparative And Strategic Research

Secondary is the evaluation how systems are positioned relative to other operators and assets within the same environment. Analyzing scale/market size, research/development and capital deployement patterns,  capability development, infrastructure build outs, technology adoption, geographic optimizations, cost positioning, and scale dynamics across comparable businesses.

Our focus is on relative position than absolute description. This includes identifying which operators are advancing capabilities, which systems are being modernized, where capital is being concentrated, and where assets remain underdeveloped or misaligned with the direction of the market. A business may have the underlying system required to compete but lack the capital, technical capability, operating model, infrastructure, or ownership structure necessary to match that direction.

This process identifies gaps such as undercapitalization, misaligned ownership, lack of technical capability, outdated operating structures, or fragmentation within a market. It determines whether those gaps can be closed through acquisition, capital investment, operational redesign, consolidation, separation, or repositioning. The outcome is a clear view of what the asset is today relative to what it must become in order to compete effectively.

Use Of Specialized Partners

Research defines the direction of the opportunity and is translated into structure through the use of specialized partners across financial engineering, restructuring, transaction execution, and operations. These partners are embedded into the evaluation process and directly influence how the opportunity is structured and whether it can be realized.

Financial engineering specialists define how capital can be structured to support the transition of the asset. This includes designing the capital stack across senior secured debt, unitranche facilities, revolving credit, subordinated debt, structured instruments, preferred equity, and common equity. They assess leverage capacity, cash flow coverage, covenant structure, liquidity profile, priority of claims, and refinancing pathways. They determine how returns are distributed, how downside is protected, and how flexibility is maintained over time. Capital is treated as a design variable that shapes the outcome of the business rather than as a fixed input.

Restructuring and transaction specialists evaluate ownership, governance, and balance sheet alignment. They determine whether the current structure of the business is constraining performance and how it can be reorganized. This includes recapitalization, separation of divisions, consolidation of assets, debt renegotiation, conversion of debt to equity, and reconfiguration of ownership to enable further development or liquidity. They define transaction pathways such as acquisitions, carve outs, staged ownership structures, or asset level reorganizations.

Operating partners assess whether the proposed direction of the business can be executed in practice. Their work focuses on process redesign, capacity expansion, cost structure adjustment, margin improvement, integration of new capabilities, and scalability limits. They determine execution timelines and operational constraints, ensuring that technical and financial conclusions can be implemented within real operating environments.

Operating Across The Lifecycle

SKGP operates across the full lifecycle of assets and businesses, from early development through growth, mature operation, and restructuring. Each stage is defined by the level of uncertainty, the quality of information available, the accessibility of capital, and the degree of operational stability.

Early stages are defined by technical validation and high uncertainty. Growth stages are defined by scaling operations and expanding capability. Mature stages are defined by optimization, efficiency, and capital structure refinement. Distressed stages are defined by misalignment between the asset and its capital structure, ownership, or operating condition.

Transitions between these stages occur through identifiable changes in system capability, infrastructure, or financial condition. Each transition reduces uncertainty and increases the range of capital and ownership structures that can be applied. SKGP focuses on identifying these transition points and structuring capital and execution to capture the change in value that occurs as the asset advances.

System Domains

Physical systems include - natural resource extraction, mining, energy systems, power generation, transmission networks, industrial processing, manufacturing facilities, logistics networks, transportation infrastructure, ports, shipping, aviation systems, rail networks, trucking, warehousing, real estate, land, agriculture infrastructure, water systems, waste systems, environmental systems, data center infrastructure, and space infrastructure including launch, satellite, and orbital systems.These systems are governed by physics, chemistry, materials, geography, energy input, and infrastructure constraints, and require capital intensive deployment, continuous maintenance, and long term operational management.

Biological systems include -  diagnostics platforms, molecular testing, genomics, proteomics, clinical laboratories, imaging systems, specialty care platforms, provider networks, pharmaceutical development, biotechnology, life science research, contract research and manufacturing services, medical devices, medical supply chains, health data systems, and disease focused platforms.These systems are governed by biological mechanisms, molecular interactions, signal detection, clinical workflows, regulatory structure, and reimbursement dynamics, and require integration between scientific discovery, clinical execution, manufacturing, and distribution.

Engineered systems include - computational platforms, compute infrastructure, chip design, semiconductor systems, embedded systems, cloud infrastructure, distributed systems, networking systems, telecommunications, satellite and sensing systems, data infrastructure, data pipelines, storage systems, real time processing systems, geospatial and scientific data systems, artificial intelligence systems, machine learning models, simulation platforms, digital modeling, optimization systems, control systems, automation, robotics, autonomous systems, quantum computing, cybersecurity systems, and operational software including enterprise systems, workflow orchestration, and decision platforms that coordinate physical and biological systems. These systems function as sensing, modeling, decision, and execution layers that monitor, optimize, scale, and coordinate operations across other system types.

Contact

Connect With SKGP

LP Inquiries